Aliskiren: first-in-class antihypertensive a big act to follow

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1542, 2006-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-in-class glycylcycline broadens its horizons to CAP

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Aliskiren plus valsartan a compelling antihypertensive combo

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives

By Oh Byung-Hee

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2839-2849

Informa Healthcare

Access to resources Recommend Favorite

MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy

By Nawrocki Steffan T Griffin Patrick Kelly Kevin R Carew Jennifer S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1563-1573

Informa Healthcare

Access to resources Recommend Favorite

The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4258-4264

Bentham Science Publishers

Access to resources Recommend Favorite